GL1X · GenesisL1 explorer

Research workbench

Crystal structure of ZmCKO4a in complex with inhibitor 1-[2-(2-Hydroxy-ethyl)-phenyl]-3-(3-trifluoromethoxy-phenyl)-urea

Analyse Crystal structure of ZmCKO4a in complex with inhibitor… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6YAO
Type
protein
Length
453 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2
Source
Zea mays
Molecule
Cytokinin dehydrogenase 4
EC
1.5.99.12
UniProt
E3T1W8
Ligands
FAD, OJ2
Pockets
6 · best druggability 0.83

Structure

x-ray diffraction · resolution 2 · 1 distinct chain · 33% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACytokinin dehydrogenase 4 (EC 1.5.99.12)protein45333% helix, 24% strandE3T1W8

Ligands and binding sites

  • FAD · Flavin-adenine dinucleotide · ligand · chains A
  • OJ2 · 1-[2-(2-Hydroxy-ethyl)-phenyl]-3-(3-trifluoromethoxy-phenyl)-urea · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 4 copies · chains A
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
19980.830.8498FAD, OJ2, DMS
21070.440.7918empty
31110.380.7519empty
4840.370.7723empty
5620.370.7916empty

Modifications

Observed in the structure: 1 cofactor (flavinylation).

Compared structures

  • 6YAO · Crystal structure of ZMCKO4A in complex with inhibitor 1-[2-(2… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.